Advertisement

Topics

Search Results for "Biochemistry Leukemia"

15:21 EST 4th December 2016 | BioPortfolio

Matching Channels

Chronic Leukemia

Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...

Acute Leukemia

Acute leukemia occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia...

Acute Myelocytic Leukemia AML

Acute myelocytic leukemia is a life-threatening disease in which the neutrophil, basophil, eosinophil, and monocyte precursors become cancerous and rapidly replace normal cells in the bone marrow. ...

Chronic Myelocytic Leukemia CML

Chronic myelocytic leukemia is the resulting disease when neutrophil, basophil, eosinophil, and monocyte progenitors become cancerous. It is usually caused by the presence of the Philadelphia chromo...

Acute Lymphocytic Leukemia ALL

Acute lymphocytic leukemia (ALL) is a life-threatening disease in which the cells that normally develop into lymphocytes become cancerous and rapidly replace normal cells in the bone marrow. ALL acc...

Matching News

Leukemia-free survival in myeloid leukemia, but not in lymphoid leukemia, is predicted by early CD4+ reconstitution following unrelated cord blood transplantation in children: a multicenter retrospective cohort analysis

Chronic Lymphocytic Leukemia and Hairy Cell Leukemia

This slide show on chronic lymphocytic leukemia (CLL) and hairy cell leukemia includes images of atypical lymphocytes, the disease in bone marrow aspirates, involved in other organs, and more.

5 Questions on the Diagnosis of Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults, and annually accounts for the majority of deaths from acute leukemia in the United States. Test your knowledge abou...

Leukemia therapeutics treatment market to grow

About 90% of the leukemia cases occur in the middle age and progresses with the aging. Therefore, leukemia therapeutics market is poised to grow with the rise in aging population and increasing incide...

luminometers, electrophoresis, analytical instruments, biochemistry, cell biology, neuroscience

Manufacturer of, molecular biology, biochemistry, bioluminescence, immunology, reagent systems, luminometers

New insight into why leukemia drug is successful

At the moment, chronic lymphocytic leukemia (CLL) is incurable. But in recent years, new drugs called B-cell receptor (BCR) inhibitors, have revolutionized treatment. Research now sheds light on why a...

Faulty Genetic Instructions Drive Deadly Leukemia in Adults

Acute myeloid leukemia is one of the most common acute leukemia or blood cancer types in adults, and involves over-production...

PR1 Peptide Vaccine May Aid Leukemia Remission

PR1 peptide vaccine may benefit many patients with myeloid leukemia, chronic myeloid leukemia and myelodysplastic syndrome, findings from an early clinical trial suggest. Reuters Health Information

Matching PubMed Articles

Role of Beclin-1-Mediated Autophagy in the Survival of Pediatric Leukemia Cells.

Acute and chronic leukemia are severe malignant cancers worldwide, and can occur in pediatric patients. Since bone marrow cell transplantation is seriously limited by the availability of the immune-pa...

Anti-Leukemic Activity of Shikonin: Role of ERP57 in Shikonin Induced Apoptosis in Acute Myeloid Leukemia.

ER-Stress and activation of unfolded protein response belong to the major factors involved in chemoresistance in cancer cells. In this study we investigated the effect of shikonin on the survival of a...

Role of microRNAs in regulation of the TNF/TNFR gene superfamily in chronic lymphocytic leukemia.

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. The biology of this disease remains elusive. In the present times, targeted molecular therapy defines the treatment...

PEITC in End-Stage B-Cell Prolymphocytic Leukemia: Case Report of Possible Sensitization to Salvage R-CHOP.

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive leukemia distinct from chronic lymphocytic leukemia, with median survival of only 3 years. B-PLL is resistant to most chemotherapy and newe...

Cutaneous manifestations in leukemia patients.

Cutaneous complications are common in patients with leukemia. However, the cause is not always immediately clear, as there are often numerous potential etiologies. Thrombocytopenia or coagulopathy can...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement